Medtronic acquires Nutrino Health to augment diabetes capabilities with Nutrino’s nutritional database and data science. Medtronic, a provider of medical technology announced it will acquire Tel Aviv-based Nutrino Health, a provider of nutrition-related data services, analytics, and technologies. For Medtronic, the acquisition is an opportunity to improve clinical outcomes for people with diabetes through the integration of Nutrino’s extensive food analysis infrastructure, nutrition science
Read More
Medtronic| Medical Technology Services & Solutions | News, Analysis, Insights - HIT Consultant
Medtronic and UnitedHealthcare’s Value-based Relationship Results in Lower Costs, Fewer Hospital Readmissions
Today, Medtronic and UnitedHealthcare announced positive first-year results from their value-based relationship focused on improving health outcomes for people with diabetes. Results demonstrated cost-savings and reduced hospital admissions for UnitedHealthcare members with type 1 diabetes on Medtronic insulin pumps, when compared to other members on multiple daily injections (MDI) of insulin. Starting in 2016, more than 6,000 UnitedHealthcare members were given access to the Medtronic MiniMed
Read More
DreaMed Diabetes Granted FDA Approval for Personalized Diabetes Decision Support Solution
DreaMed Diabetes, an Israeli-based developer of personalized diabetes management solutions, today announced that the U.S Food and Drug Administration (FDA) has granted a De Novo request for DreaMed Advisor Pro, an artificial intelligence (AI)-based diabetes treatment decision support software. Advisor Pro is indicated to assist healthcare providers in the management of people with type 1 diabetes who use insulin pumps and continuous glucose monitoring (CGM).The announcement marks the second
Read More
FDA Approves Medtronic Smart Continuous Glucose Monitoring (CGM) System for Diabetes
The FDA has just approved the Medtronic Guardian™ Connect Continuous Glucose Monitoring (CGM) system, the first smart CGM system to help people with diabetes outsmart high and low glucose events. The system uses the power of real-time sensor glucose data, advanced algorithms and customizable, predictive alerts to notify people when sensor glucose levels are predicted to go too high or low – up to 60 minutes in advance.Understanding Continuous Glucose Monitoring (CGM)A CGM system provides
Read More
Medtronic Receives FDA Approval for New Arm Indication for Continuous Glucose Monitoring System
Medtronic today announced that the FDA has approved a new arm indication for the Guardian Sensor 3, the company’s most accurate continuous glucose monitoring system and the only sensor approved in the U.S. to help control automated insulin delivery for patient with diabetes via its hybrid closed loop system – the MiniMed 670G system.This expanded indication will enable patients to wear the sensor on the upper arm, providing improved flexibility, enhanced performance for users, as well as
Read More
Medtronic, Philips Partner Develop Innovation Solution for Lung Cancer
Medtronic and Philips, today announced a new partnership to develop and commercialize the LungGPS Patient Management Platform. The comprehensive patient and data management platform is designed to make it easier for clinicians to identify and manage potentially cancerous lung nodules.Lung cancer is the deadliest form of cancer, and while early detection is key, there are few symptoms in the earlier stages. When found early, lung nodules can be continuously monitored for growth, which is a sign
Read More
Medtronic, American Well Partner to Integrate Telehealh Services and Enable Bi-Directional Data Flow
Medtronic has announced an integration partnership with telehealth provider American Well to enable a more complete telehealth solution focused on the unique needs of the complex, chronic, co-morbid patient population. The goal of the partnership is to provide greater patient access to their care team, while improving clinician access to the critical information needed when making care decisions - especially as they evaluate opportunities for early intervention.As part of the integration
Read More
Medtronic, Aetna Form Outcomes-Based Partnership for Diabetic Patients
Medtronic, a medical technology provider has entered into a new outcomes-based, risk-sharing agreement with Aetna for type 1 and type 2 diabetes patients currently on multiple daily insulin injections for their diabetes management. The agreement will measure health outcomes for a patient with diabetes who transition to Medtronic’s insulin pump therapy that constantly self-adjusts to keep patients’ blood sugar levels in range based on their personalized needs.This outcomes-based, risk-sharing
Read More
Medtronic Integrates With Fitbit to Understand How Exercise Impacts Glucose Levels
Medtronic has announced a partnership with connected health provider Fitbit to integrate health and activity tracking to physicians and care teams for patients living with diabetes. With this integration, patients with Type 2 diabetes will be able to monitor their glucose levels and physical activity data via Medtronic's iPro(TM)2 myLog mobile app. Together, the partnership will provide meaningful insight on how exercise impacts glucose levels for more effective diabetes care
Read More
Medtronic To Acquire Heartware for $1.1B: 9 Things to Know
On Monday, medical device maker Medtronic entered a definitive agreement to acquire HeartWare International Inc. an innovator of less-invasive, miniaturized circulatory support technologies for the treatment of advanced heart failure for $1.1 billion. The acquisition is expected to close during Medtronic's second fiscal quarter ending Oct. 28, 2016. Here are 9 things to know about the acquisition: 1. As part of the agreement, Medtronic will pay $58 for each Heartware share outstanding, which
Read More
